SYSMEX Corp/ADR (OTCMKTS:SSMXY) issued an update on its FY 2018 earnings guidance on Wednesday morning. The company provided EPS guidance of $1.67-1.67 for the period. The company issued revenue guidance of $2.64-2.64 billion.
Shares of SSMXY opened at $29.14 on Friday. The firm has a market cap of $14.56 billion, a price-to-earnings ratio of 43.67 and a beta of 0.55. SYSMEX Corp/ADR has a 12 month low of $29.07 and a 12 month high of $50.46.
Separately, ValuEngine cut shares of SYSMEX Corp/ADR from a buy rating to a hold rating in a research report on Wednesday.
Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, sale, and export/import of diagnostic instruments, reagents, and related software for the use in hematology, urinalysis, immunochemistry, clinical chemistry, and hemostasis. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; systems for high-volume testing in labs; and hematology analyzers for animals.
Further Reading: Hedge Funds Explained
Receive News & Ratings for SYSMEX Corp/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SYSMEX Corp/ADR and related companies with MarketBeat.com's FREE daily email newsletter.